NFE2L3 and cancer: Thus, our study demonstrated that NFE2L3 expression was upregulated in a variety of cancers and was associated with poor prognosis, consistent with previous reports (Wang et al., 2018; Bury et al., 2019; Dai et al., 2021; Wang et al., 2021; Qian et al., 2022).